Selected article for: "Antibody testing and ELISA immunosorbent assay"

Author: MacMullan, Melanie A.; Ibrayeva, Albina; Trettner, Kylie; Deming, Laura; Das, Sudipta; Tran, Frances; Moreno, Jose Ricardo; Casian, Joseph G.; Chellamuthu, Prithivi; Kraft, Jeffrey; Kozak, Kenneth; Turner, Fred E.; Slepnev, Vladimir I.; Le Page, Lydia M.
Title: ELISA detection of SARS-CoV-2 antibodies in saliva
  • Cord-id: ckjzr31j
  • Document date: 2020_11_30
  • ID: ckjzr31j
    Snippet: To facilitate containment of the COVID-19 pandemic currently active in the United States and across the world, options for easy, non-invasive antibody testing are required. Here we have adapted a commercially available, serum-based enzyme-linked immunosorbent assay (ELISA) for use with saliva samples, achieving 84.2% sensitivity and 100% specificity in a set of 149 clinical samples. This strategy will enable widespread, affordable testing for patients who experienced this disease, whilst minimiz
    Document: To facilitate containment of the COVID-19 pandemic currently active in the United States and across the world, options for easy, non-invasive antibody testing are required. Here we have adapted a commercially available, serum-based enzyme-linked immunosorbent assay (ELISA) for use with saliva samples, achieving 84.2% sensitivity and 100% specificity in a set of 149 clinical samples. This strategy will enable widespread, affordable testing for patients who experienced this disease, whilst minimizing exposure risk for healthcare workers.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1